Previous research by our group showed that DMOG, an unspecific prolyl-hydroxylase inhibitor, can upregulate nuclear HIF-1α and the chemokine CXCL12 in the mouse heart after MI, leading to improved cardiac repair [23]. Here, CXCL12 is linked to myocardial infarction.